The post SEC Receives Application for Staked INJ ETF Approval appeared on BitcoinEthereumNews.com. Key Points: The U.S. SEC evaluates Canary Capital’s proposed Staked INJ ETF. First ETF combining Injective Protocol with staking rewards. SEC’s review period signals regulatory openness to staking-based ETFs. The U.S. Securities and Exchange Commission (SEC) has received an application from Canary Capital for the Canary Staked INJ ETF, intending to provide regulated staking exposure to INJ tokens. Approval could position this ETF as a pioneering financial instrument, integrating staking returns into traditional investing, potentially influencing liquidity and value dynamics in the Injective Protocol’s ecosystem. Canary Capital’s Staked INJ ETF: A Regulatory Milestone Canary Capital, led by Steven McClurg, submitted a proposal for a Staked INJ ETF via Cboe’s platform, aiming to integrate Injective Protocol and staking rewards within an ETF structure. While this represents a milestone, official statements from Injective Labs are pending. If approved, the ETF would offer investors access to Injective Protocol without technical hurdles, potentially boosting its ecosystem. This innovation follows the SEC’s recent clarifications on staking activities. Market analysts anticipate heightened interest, although institutional sentiment varies. Investors and developers are closely monitoring the SEC’s position, which may shape future regulatory frameworks for crypto ETFs. Injective Protocol: Expert Views and Market Data Did you know? Canary Capital’s application is part of broader efforts to offer a diversified range of ETFs, including those involving major Layer-1 networks. According to CoinMarketCap, the current market cap for Injective (INJ) stands at $1.29 billion, with a price of $12.91. Despite a recent decline in trading volume and price, INJ gained 21.03% over the past two months, reflecting interest amidst evolving market conditions. Injective(INJ), daily chart, screenshot on CoinMarketCap at 06:35 UTC on August 26, 2025. Source: CoinMarketCap Coincu’s research team highlights that this ETF approach might lead to increased liquidity, aligning with past trends where ETF approvals positively influenced market… The post SEC Receives Application for Staked INJ ETF Approval appeared on BitcoinEthereumNews.com. Key Points: The U.S. SEC evaluates Canary Capital’s proposed Staked INJ ETF. First ETF combining Injective Protocol with staking rewards. SEC’s review period signals regulatory openness to staking-based ETFs. The U.S. Securities and Exchange Commission (SEC) has received an application from Canary Capital for the Canary Staked INJ ETF, intending to provide regulated staking exposure to INJ tokens. Approval could position this ETF as a pioneering financial instrument, integrating staking returns into traditional investing, potentially influencing liquidity and value dynamics in the Injective Protocol’s ecosystem. Canary Capital’s Staked INJ ETF: A Regulatory Milestone Canary Capital, led by Steven McClurg, submitted a proposal for a Staked INJ ETF via Cboe’s platform, aiming to integrate Injective Protocol and staking rewards within an ETF structure. While this represents a milestone, official statements from Injective Labs are pending. If approved, the ETF would offer investors access to Injective Protocol without technical hurdles, potentially boosting its ecosystem. This innovation follows the SEC’s recent clarifications on staking activities. Market analysts anticipate heightened interest, although institutional sentiment varies. Investors and developers are closely monitoring the SEC’s position, which may shape future regulatory frameworks for crypto ETFs. Injective Protocol: Expert Views and Market Data Did you know? Canary Capital’s application is part of broader efforts to offer a diversified range of ETFs, including those involving major Layer-1 networks. According to CoinMarketCap, the current market cap for Injective (INJ) stands at $1.29 billion, with a price of $12.91. Despite a recent decline in trading volume and price, INJ gained 21.03% over the past two months, reflecting interest amidst evolving market conditions. Injective(INJ), daily chart, screenshot on CoinMarketCap at 06:35 UTC on August 26, 2025. Source: CoinMarketCap Coincu’s research team highlights that this ETF approach might lead to increased liquidity, aligning with past trends where ETF approvals positively influenced market…

                                                                               BitGo’s move creates further competition in a burgeoning European crypto market that is expected to generate $26 billion revenue this year, according to one estimate.                     BitGo, a digital asset infrastructure company with more than $100 billion in assets under custody, has received an extension of its license from Germany’s Federal Financial Supervisory Authority (BaFin), enabling it to offer crypto services to European investors. The company said its local subsidiary, BitGo Europe, can now provide custody, staking, transfer, and trading services. Institutional clients will also have access to an over-the-counter (OTC) trading desk and multiple liquidity venues.The extension builds on BitGo’s previous Markets-in-Crypto-Assets (MiCA) license, also issued by BaFIN, and adds trading to the existing custody, transfer and staking services. BitGo acquired its initial MiCA license in May 2025, which allowed it to offer certain services to traditional institutions and crypto native companies in the European Union.Read more